vs

Side-by-side financial comparison of AMREP CORP. (AXR) and Ceribell, Inc. (CBLL). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $14.6M, roughly 1.7× AMREP CORP.). AMREP CORP. runs the higher net margin — 21.6% vs -54.6%, a 76.2% gap on every dollar of revenue. AMREP CORP. produced more free cash flow last quarter ($5.4M vs $-11.0M).

AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

AXR vs CBLL — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.7× larger
CBLL
$24.8M
$14.6M
AXR
Higher net margin
AXR
AXR
76.2% more per $
AXR
21.6%
-54.6%
CBLL
More free cash flow
AXR
AXR
$16.3M more FCF
AXR
$5.4M
$-11.0M
CBLL

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AXR
AXR
CBLL
CBLL
Revenue
$14.6M
$24.8M
Net Profit
$3.1M
$-13.5M
Gross Margin
87.3%
Operating Margin
20.6%
-58.9%
Net Margin
21.6%
-54.6%
Revenue YoY
93.8%
Net Profit YoY
338.9%
EPS (diluted)
$0.58
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXR
AXR
CBLL
CBLL
Q1 26
$14.6M
Q4 25
$9.4M
$24.8M
Q3 25
$17.9M
$22.6M
Q2 25
$11.2M
$21.2M
Q1 25
$7.5M
$20.5M
Q4 24
$11.9M
Q3 24
$19.1M
$17.2M
Q2 24
$19.5M
Net Profit
AXR
AXR
CBLL
CBLL
Q1 26
$3.1M
Q4 25
$1.2M
$-13.5M
Q3 25
$4.7M
$-13.5M
Q2 25
$3.9M
$-13.6M
Q1 25
$717.0K
$-12.8M
Q4 24
$4.0M
Q3 24
$4.1M
$-10.4M
Q2 24
$4.1M
Gross Margin
AXR
AXR
CBLL
CBLL
Q1 26
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Operating Margin
AXR
AXR
CBLL
CBLL
Q1 26
20.6%
Q4 25
11.9%
-58.9%
Q3 25
34.4%
-64.8%
Q2 25
31.7%
-70.5%
Q1 25
5.7%
-69.3%
Q4 24
26.4%
Q3 24
26.1%
-57.8%
Q2 24
23.9%
Net Margin
AXR
AXR
CBLL
CBLL
Q1 26
21.6%
Q4 25
12.8%
-54.6%
Q3 25
26.3%
-59.6%
Q2 25
34.8%
-64.4%
Q1 25
9.5%
-62.4%
Q4 24
33.9%
Q3 24
21.3%
-60.6%
Q2 24
21.2%
EPS (diluted)
AXR
AXR
CBLL
CBLL
Q1 26
$0.58
Q4 25
$0.22
$-0.35
Q3 25
$0.87
$-0.37
Q2 25
$0.73
$-0.38
Q1 25
$0.13
$-0.36
Q4 24
$0.75
Q3 24
$0.76
$-1.85
Q2 24
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXR
AXR
CBLL
CBLL
Cash + ST InvestmentsLiquidity on hand
$50.0M
$159.3M
Total DebtLower is stronger
$21.0K
Stockholders' EquityBook value
$139.4M
$155.3M
Total Assets
$143.9M
$195.8M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXR
AXR
CBLL
CBLL
Q1 26
$50.0M
Q4 25
$44.6M
$159.3M
Q3 25
$48.9M
$168.5M
Q2 25
$39.5M
$177.4M
Q1 25
$36.9M
$182.7M
Q4 24
$40.1M
Q3 24
$40.4M
$14.1M
Q2 24
$29.7M
Total Debt
AXR
AXR
CBLL
CBLL
Q1 26
$21.0K
Q4 25
$23.0K
Q3 25
$25.0K
Q2 25
$26.0K
Q1 25
$29.0K
Q4 24
$32.0K
Q3 24
$34.0K
Q2 24
$35.0K
Stockholders' Equity
AXR
AXR
CBLL
CBLL
Q1 26
$139.4M
Q4 25
$136.0M
$155.3M
Q3 25
$134.7M
$164.1M
Q2 25
$130.0M
$172.2M
Q1 25
$126.0M
$180.9M
Q4 24
$125.1M
Q3 24
$122.2M
$-136.0M
Q2 24
$118.0M
Total Assets
AXR
AXR
CBLL
CBLL
Q1 26
$143.9M
Q4 25
$140.1M
$195.8M
Q3 25
$140.7M
$199.5M
Q2 25
$133.8M
$207.7M
Q1 25
$128.9M
$213.5M
Q4 24
$129.1M
Q3 24
$127.0M
$47.1M
Q2 24
$122.8M
Debt / Equity
AXR
AXR
CBLL
CBLL
Q1 26
0.00×
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXR
AXR
CBLL
CBLL
Operating Cash FlowLast quarter
$5.4M
$-10.8M
Free Cash FlowOCF − Capex
$5.4M
$-11.0M
FCF MarginFCF / Revenue
37.0%
-44.2%
Capex IntensityCapex / Revenue
0.1%
0.7%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$20.2M
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXR
AXR
CBLL
CBLL
Q1 26
$5.4M
Q4 25
$-4.3M
$-10.8M
Q3 25
$9.5M
$-11.1M
Q2 25
$10.2M
$-7.5M
Q1 25
$-3.2M
$-11.4M
Q4 24
$-182.0K
Q3 24
$10.7M
Q2 24
$10.7M
Free Cash Flow
AXR
AXR
CBLL
CBLL
Q1 26
$5.4M
Q4 25
$-4.3M
$-11.0M
Q3 25
$9.5M
$-11.5M
Q2 25
$9.7M
$-7.6M
Q1 25
$-3.3M
$-11.6M
Q4 24
$-268.0K
Q3 24
$10.7M
Q2 24
$10.3M
FCF Margin
AXR
AXR
CBLL
CBLL
Q1 26
37.0%
Q4 25
-45.9%
-44.2%
Q3 25
53.2%
-50.8%
Q2 25
86.4%
-35.9%
Q1 25
-43.4%
-56.4%
Q4 24
-2.3%
Q3 24
55.8%
Q2 24
52.5%
Capex Intensity
AXR
AXR
CBLL
CBLL
Q1 26
0.1%
Q4 25
0.6%
0.7%
Q3 25
0.1%
1.6%
Q2 25
5.2%
0.3%
Q1 25
0.3%
0.7%
Q4 24
0.7%
Q3 24
0.2%
Q2 24
2.3%
Cash Conversion
AXR
AXR
CBLL
CBLL
Q1 26
1.72×
Q4 25
-3.54×
Q3 25
2.03×
Q2 25
2.63×
Q1 25
-4.51×
Q4 24
-0.05×
Q3 24
2.63×
Q2 24
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXR
AXR

Segment breakdown not available.

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

Related Comparisons